Eric Shaff
Chief Executive Officer at SERES THERAPEUTICS, INC.
Net worth: 104 738 $ as of 2023-07-30
Profile
Eric D.
Shaff is currently the President, Chief Executive Officer & Director at Seres Therapeutics, Inc. He previously served as an Independent Director at Sigilon Therapeutics, Inc. from 2017 to 2023.
Eric also worked as a Principal at Pfizer Inc. and as the Global Head-Rare Genetic Disease Finance at Genzyme Corp.
from 2004 to 2011.
Additionally, he held the position of Vice President-Corporate Finance at Momenta Pharmaceuticals, Inc. from 2012 to 2014.
Eric started his career as a Senior Analyst at Broadview International LLC.
He completed his undergraduate studies at the University of Pennsylvania and earned an MBA from the Johnson Graduate School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SERES THERAPEUTICS INC
0.09% | 2024-02-15 | 135,321 ( 0.09% ) | 104 738 $ | 2024-03-30 |
| 2023-08-10 | 0 ( -.--% ) | - $ | 2023-07-30 |
Eric Shaff active positions
| Companies | Position | Start |
|---|---|---|
| SERES THERAPEUTICS, INC. | Chief Executive Officer | 2019-01-14 |
Former positions of Eric Shaff
| Companies | Position | End |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Director/Board Member | 2023-08-10 |
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2014-10-31 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2011-11-30 |
| PFIZER, INC. | Corporate Officer/Principal | - |
Broadview International LLC
 Broadview International LLC Investment Banks/BrokersFinance Jefferies Broadview, a division of Jefferies & Company, Inc. provides services to the information technology, communications, healthcare technology and digital media industries. The firm addresses six major technology segments: communications technology, semiconductors and electronics manufacturing, enterprise software, digital media, and information technology services. Jefferies Broadview consists of 90 investment bankers operating in the US, Europe and Asia. The company provides investment banking services including debt and equity underwriting, private placements, M&A and restructuring advisory services. The company is headquartered in New York, NY. | Corporate Officer/Principal | - |
Training of Eric Shaff
| University of Pennsylvania | Undergraduate Degree |
| Johnson Graduate School of Management | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| SERES THERAPEUTICS, INC. | Health Technology |
| SIGILON THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Broadview International LLC
Broadview International LLC Investment Banks/BrokersFinance Jefferies Broadview, a division of Jefferies & Company, Inc. provides services to the information technology, communications, healthcare technology and digital media industries. The firm addresses six major technology segments: communications technology, semiconductors and electronics manufacturing, enterprise software, digital media, and information technology services. Jefferies Broadview consists of 90 investment bankers operating in the US, Europe and Asia. The company provides investment banking services including debt and equity underwriting, private placements, M&A and restructuring advisory services. The company is headquartered in New York, NY. | Finance |
- Stock Market
- Insiders
- Eric Shaff
